Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The endothelial cells that form capillaries in the brain are highly specialized, with tight junctions that minimize paracellular transport and an array of broad-spectrum efflux pumps that make drug delivery to the brain extremely challenging. One of the major limitations in blood-brain barrier research and the development of drugs to treat central nervous system diseases is the lack of appropriate cell lines. Recent reports indicate that the derivation of human brain microvascular endothelial cells (hBMECs) from human induced pluripotent stem cells (iPSCs) may provide a solution to this problem. Here we demonstrate the derivation of hBMECs extended to two new human iPSC lines: BC1 and GFP-labeled BC1. These hBMECs highly express adherens and tight junction proteins VE-cadherin, ZO-1, occludin, and claudin-5. The addition of retinoic acid upregulates VE-cadherin expression, and results in a significant increase in transendothelial electrical resistance to physiological values. The permeabilities of tacrine, rhodamine 123, and Lucifer yellow are similar to values obtained for MDCK cells. The efflux ratio for rhodamine 123 across hBMECs is in the range 2-4 indicating polarization of efflux transporters. Using the rod assay to assess cell organization in small vessels and capillaries, we show that hBMECs resist elongation with decreasing diameter but show progressive axial alignment. The derivation of hBMECs with a blood-brain barrier phenotype from the BC1 cell line highlights that the protocol is robust. The expression of GFP in hBMECs derived from the BC1-GFP cell line provides an important new resource for BBB research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dhBMEC monolayers express a wide range of BBB markers, including tight junction (TJ) proteins (Fig. 1b), transporters, and efflux pumps, and typically attain transendothelial electrical resistance (TEER) > 1500 Ω cm2 [27, 28, 31, 34–37].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“IMR90-4 was induced from fetal fibroblasts using lentiviral vectors; DF6-9-9T and DF19-9-11T were both induced from foreskin fibroblasts using the oriP/EBNA-1 episomal vector [15, 16].”
MethodStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Claudins and the Modulation of Tight Junction Permeability
Günzel, D., & Yu, A. S. L. (2013) · Physiological Reviews · doi:10.1152/physrev.00019.2012 · Cited by 1,456 · cited 1×
“Some claudins have been reported to show nuclear localization [35].”
BackgroundMethods in molecular medicine.
Craig, R. K. (1987) · BMJ · doi:10.1136/bmj.295.6599.646 · Cited by 1,057
The role of adherens junctions and VE-cadherin in the control of vascular permeability
Dejana, E., Orsenigo, F., & Lampugnani, M. G. (2008) · Journal of Cell Science · doi:10.1242/jcs.017897 · Cited by 986 · cited 1×
“Vascular endothelial cadherin (VE-cad) is an adherens junction protein specific to endothelial cells [37].”
BackgroundMDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
Morita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 869
Research works printed but not linked: 1
- Zou C, Chou BK, Dowey SN, Tsang K, Huang X, Liu CF, et al Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines. Stem Cells Dev. 2012; 21(12): 2298– 311. Epub 2012/01/10. 10.1089/scd.2011.0688 22225458 PMC3411364 · DOI
Cited by
Vatine, G. D., Barrile, R., Workman, M. J., Sances, S., Barriga, B. K., Rahnama, M., Barthakur, S., Kasendra, M., Lucchesi, C., Kerns, J., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.011 · Cited by 632
Park, T.-E., Mustafaoglu, N., Herland, A., Hasselkus, R., Mannix, R., FitzGerald, E. A., Prantil-Baun, R., Watters, A., Henry, O., Benz, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10588-0 · Cited by 594
Blood-brain barrier transport machineries and targeted therapy of brain diseases
Barar, J., Rafi, M. A., Pourseif, M. M., & Omidi, Y. (2016) · BioImpacts · doi:10.15171/bi.2016.30 · Cited by 257
Linville, R. M., DeStefano, J. G., Sklar, M. B., Xu, Z., Farrell, A. M., Bogorad, M. I., Chu, C., Walczak, P., Cheng, L., Mahairaki, V., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.023 · Cited by 199
“Human induced pluripotent stem cells (iPSCs) differ entiated into BMECs (dhBMECs) display many of the hallmarks of the BBB in two-dimensional (2D) transwell assays including physiological TEER, permeability and efflux behavio r.(13-16) Interestingly, BBB phenotype is achieved without supporting cell types.”
MethodSelf-citationHollmann, E. K., Bailey, A. K., Potharazu, A. V., Neely, M. D., Bowman, A. B., & Lippmann, E. S. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0059-0 · Cited by 189
“to BMECs Previous protocols to differentiate iPSCs to BMECs relied on seeding iPSCs at defined densities, expanding the cells in mTeSR media for 3 days [26], and differentiating the cells for 6 days in UM to immature BMECs [24, 25, 37, 39].”
Effect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs)
DeStefano, J. G., Xu, Z. S., Williams, A. J., Yimam, N., & Searson, P. C. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0068-z · Cited by 153
“Details of the differentiation and characterization of the hBMECs have been reported elsewhere [4].”
Self-citationRibecco-Lutkiewicz, M., Sodja, C., Haukenfrers, J., Haqqani, A. S., Ly, D., Zachar, P., Baumann, E., Ball, M., Huang, J., Rukhlova, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19522-8 · Cited by 148
Benchmarking in vitro tissue-engineered blood–brain barrier models
DeStefano, J. G., Jamieson, J. J., Linville, R. M., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0117-2 · Cited by 142
Self-citationBioengineering methods for vascularizing organoids
Nwokoye, P. N., & Abilez, O. J. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100779 · Cited by 187
“120 Intriguingly, targeted activation of specific signaling pathways (e.g., Wnt, Notch) with small molecules offers a complementary, potentially more chemically defined approach for recapitulating BMEC development from hPSCs. 121 Despite their widespread use, it is crucial to recognize the inherent…”
BackgroundJamieson, J. J., Linville, R. M., Ding, Y. Y., Gerecht, S., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0136-7 · Cited by 117
Self-citationGrifno, G. N., Farrell, A. M., Linville, R. M., Arevalo, D., Kim, J. H., Gu, L., & Searson, P. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-50193-1 · Cited by 112
Self-citationCommentary on human pluripotent stem cell-based blood–brain barrier models
Lippmann, E. S., Azarin, S. M., Palecek, S. P., & Shusta, E. V. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00222-3 · Cited by 114
Faley, S. L., Neal, E. H., Wang, J. X., Bosworth, A. M., Weber, C. M., Balotin, K. M., Lippmann, E. S., & Bellan, L. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.009 · Cited by 106
“Since these initial publications, others have validated the fidelity of these cells and advancements have been made toward improving the differentiation procedure (Appelt-Menzel et al., 2017; Hollmann et al., 2017; Katt et al., 2016; Wilson et al., 2015).”
BackgroundKatt, M. E., Linville, R. M., Mayo, L. N., Xu, Z. S., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0092-7 · Cited by 102
“dhBMECs form monolayers with expression of tight junction markers and very high TEER on glass and transwell membranes [8].”
BackgroundMethodInfluentialSelf-citationLin, Y., Gil, C.-H., & Yöder, M. C. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309962 · Cited by 111
Mantle, J. L., Min, L., & Lee, K. H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00818 · Cited by 86
Noumbissi, M. E., Galasso, B., & Stins, M. F. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0097-2 · Cited by 77
Neural Lineage Differentiation From Pluripotent Stem Cells to Mimic Human Brain Tissues
Hong, Y. J., & Do, J. T. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00400 · Cited by 75
“These hPSC-BMECs were sufficiently representative of the endothelial cells present in human BBB and were able to model the BBB phenotype when co-cultured with astrocytes and pericytes (Lippmann et al., 2012; Katt et al., 2016; Hollmann et al., 2017; Qian et al., 2017, 2019; Ribecco-Lutkiewicz et al., 2018).”
BackgroundPong, S., Karmacharya, R., Sofman, M., Bishop, J. R., & Lizano, P. L. (2020) · Complex Psychiatry · doi:10.1159/000511552 · Cited by 81
Engineering the human blood-brain barrier in vitro
Jamieson, J. J., Searson, P. C., & Gerecht, S. (2017) · Journal of Biological Engineering · doi:10.1186/s13036-017-0076-1 · Cited by 72
“PSC-derived Mouse or human iPSC or ESC 250–5350 [19, 101, 102] • renewable source • patient specific • physiological TEER • require differentiation and thorough characterization [20, 101, 102, 112] Jamieson et al.”
BackgroundSelf-citationiPSCs-based generation of vascular cells: reprogramming approaches and applications
Klein, D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2730-7 · Cited by 76
“The addition of retinoic acid in differentiated endothelial cell cultures further upregulated expression levels of the mature endothelial cell marker VE-Cadherin and resulted in a significant increase in trans-endothelial electrical resistance to physiological values [64, 65].”
BackgroundKatt, M. E., Mayo, L. N., Ellis, S., Mahairaki, V., Rothstein, J. D., Cheng, L., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0139-4 · Cited by 71
Self-citationKurosawa, T., Tega, Y., Higuchi, K., Yamaguchi, T., Nakakura, T., Mochizuki, T., Kusuhara, H., Kawabata, K., & Deguchi, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00697 · Cited by 69
Linville, R. M., DeStefano, J. G., Sklar, M. B., Chu, C., Walczak, P., & Searson, P. C. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19867980 · Cited by 67
“BC1 dhBMECs show transendothelial electrical resistance (TEER) values above 1500 cm(2) in two-dimensional culture, when cultured in media supplemented with retinoic acid.(26) BBB microvessels were fabricated as previously reported.”
MethodResultSelf-citationLinville, R. M., Sklar, M. B., Grifno, G. N., Nerenberg, R. F., Zhou, J., Ye, R., DeStefano, J. G., Guo, Z., Jha, R., Jamieson, J. J., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00377-1 · Cited by 67
“endothelial/mesodermal specification followed by brain endothelial specification, achieved via a combination of Wnt/β-catenin, VEGF, and retinoic acid-induced signaling [19-23].”
BackgroundMethodInfluentialSelf-citationPatel, R., Page, S., & Al‐Ahmad, A. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14040 · Cited by 64
Wang, Y., Gallagher, E., Jorgensen, C., Troendle, E. P., Hu, D., Searson, P. C., & Ulmschneider, M. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-42272-0 · Cited by 73
Self-citationDubey, S. K., Munnangi, S. R., Krishna, K. V., Saha, R. N., Singhvi, G., Agrawal, M., Ajazuddin, M., Saraf, S., Saraf, S., & Alexander, A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00653-z · Cited by 68
Praça, C., Rosa, S. C., Sevin, E., Cecchelli, R., Dehouck, M., & Ferreira, L. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.002 · Cited by 66
“, 2012) and RA (Katt et al., 2016; Lippmann et al., 2014) signaling was necessary for the specification of BBB properties in ECs.”
BackgroundResultEngineered nanoparticles for systemic siRNA delivery to malignant brain tumours
Karlsson, J. E., Rui, Y., Kozielski, K., Placone, A. L., Choi, O., Tzeng, S. Y., Kim, J., Keyes, J. J., Bogorad, M. I., Gabrielson, K. L., et al. (2019) · Nanoscale · doi:10.1039/c9nr04795f · Cited by 60
Self-citationCurtaz, C. J., Schmitt, C., Herbert, S.-L., Feldheim, J., Schlegel, N., Gosselet, F., Hagemann, C., Roewer, N., Meybohm, P., Wöckel, A., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00192-6 · Cited by 65
Appelt‐Menzel, A., Oerter, S., Mathew, S., Haferkamp, U., Hartmann, C., Jung, M., Neuhaus, W., & Pleß, O. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.122 · Cited by 57
Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Gillispie, G. J., Milligan, C., & Orr, M. E. (2021) · Life · doi:10.3390/life11030229 · Cited by 55
Zhang, J., Dong, B., Hao, J., Yi, S., Cai, W., & Luo, Z. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116929 · Cited by 55
Review of Design Considerations for Brain-on-a-Chip Models
Cameron, T., Bennet, T. J., Rowe, E. M., Anwer, M., Wellington, C. L., & Cheung, K. C. (2021) · Micromachines · doi:10.3390/mi12040441 · Cited by 54
Koenig, L., Ramme, A. P., Faust, D., Mayer, M., Flötke, T., Gerhartl, A., Brachner, A., Neuhaus, W., Appelt‐Menzel, A., Metzger, M., et al. (2022) · Cells · doi:10.3390/cells11203295 · Cited by 52
“Additionally, as other groups before, we observed no morphological changes such as elongation [7,32,38].”
BackgroundZhang, S., Thompson, J. P., Xia, J., Bogetti, A. T., York, F., Skillman, A. G., Chong, L. T., & LeBard, D. N. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01540 · Cited by 51
Linville, R. M., Komin, A., Lan, X., DeStefano, J. G., Chu, C., Liu, G., Walczak, P., Hristova, K. A., & Searson, P. C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120942 · Cited by 45
Self-citationPaving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells
Lauschke, K., Frederiksen, L., & Hall, V. J. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0003 · Cited by 49
“This approach yielded a differentiation efficiency of an impressive 93% and a TEER of 2,000Ocm(2) [58].”
Yamashita, M., Aoki, H., Hashita, T., Iwao, T., & Matsunaga, T. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00197-1 · Cited by 47
Retinoic acid signaling in vascular development
Pawlikowski, B. T., Wragge, J., & Siegenthaler, J. A. (2019) · genesis · doi:10.1002/dvg.23287 · Cited by 45
Tissue‐Engineered Microvessels: A Review of Current Engineering Strategies and Applications
Zhao, N., Pessell, A. F., Zhu, N., & Searson, P. C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303419 · Cited by 43
Self-citationMarco, A. D., Vignone, D., Paz, O. G., Fini, I., Battista, M. R., Cellucci, A., Bracacel, E., Auciello, G., Veneziano, M., Khetarpal, V. K., et al. (2020) · Cells · doi:10.3390/cells9040994 · Cited by 40
“57 × 10−6 cm/s) in human BMECs derived from the BC1 iPS cell line [19].”
BackgroundLi, Y., Sun, X., Liu, H., Huang, L. J., Meng, G., Ding, Y., Su, W., Lu, J., Gong, S., Terstappen, G. C., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00384-7 · Cited by 41
Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity
Pamies, D., Wiersma, D., Katt, M. E., Zhao, L., Burtscher, J., Harris, G., Smirnova, L., Searson, P. C., Härtung, T., & Högberg, H. T. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105719 · Cited by 39
“The hBMECs were maintained and derived from the BC1 iPSC line (Chou et al., 2011) as previously described (Katt et al., 2016).”
MethodSelf-citationFengler, S., Kurkowsky, B., Kaushalya, S. K., Roth, W., Fava, E., & Denner, P. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121525 · Cited by 40
Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies
Majewska, A., Wilkus, K., Brodaczewska, K. K., & Kiéda, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020520 · Cited by 37
Baringer, S. L., Palsa, K., Spiegelman, V. S., Simpson, I. A., & Connor, J. R. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00934-2 · Cited by 35
“ECs are highly polarized and exclusively express Fpn on the basolateral membrane [19, 31] that is adherent to the plate or slide surface, making it difficult to study protein interactions in this location.”
BackgroundMotallebnejad, P., & Azarin, S. M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00215-2 · Cited by 32
Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis
Linville, R. M., Arevalo, D., Maressa, J. C., Zhao, N., & Searson, P. C. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104042 · Cited by 34
Self-citationModeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells
Bosworth, A. M., Faley, S. L., Bellan, L. M., & Lippmann, E. S. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00087 · Cited by 34
“org January 2018 | Volume 5 | Article 87 characterizations (Katt et al., 2016; Appelt-Menzel et al., 2017; Kokubu et al., 2017; Lim et al., 2017; Wang et al., 2017b).”
BackgroundRecent advances in sensor-integrated brain-on-a-chip devices for real-time brain monitoring
Zhao, C., Wang, Z., Tang, X., Qin, J., & Jiang, Z. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113431 · Cited by 32
Wilson, H. K., Faubion, M. G., Hjortness, M. K., Palecek, S. P., & Shusta, E. V. (2016) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2016.0345 · Cited by 29
“Overall, iPSC-BMECs are becoming a more widespread cell source for human in vitro BBB models.(42,43) In this study, we have demonstrated that iPSC-BMECs can be cryopreserved for up to 1 year with Y-27632 supplementation post-thaw and retain BBB characteristics that rival nonfrozen iPSC-BMECs.”
Piantino, M., Louis, F., Shigemoto‐Mogami, Y., Nakayama-Kitamura, K., Sato, K., Yamaguchi, T., Kawabata, K., Yamamoto, S., Iwasaki, S., Hirabayashi, H., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100232 · Cited by 34
“The high TEER value and enhanced size-dependent selectivity of FITC dextran observed with hiPS-BMEC could result from their ability to form stronger and more stable TJs between adjacent cells than HBEC, as seen by ZO-1, VE-cadherin and Claudin-5 junctional continuity and barrier integrity (Fig.”
InfluentialAdvances in Modeling Alzheimer's Disease In Vitro
Sharma, N. S., Karan, A., Lee, D.-H., Yan, Z., & Xie, J. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100097 · Cited by 34
Burgio, F., Gaiser, C., Brady, K., Gatta, V., Class, R., Schrage, R., & Suter‐Dick, L. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01404-x · Cited by 28
“S2C) comparable to what was published (Katt et al. 2016; Stebbins et al. 2016).”
MethodInfluentialA guide for blood–brain barrier models
Soliman, Y., Al‐khodor, J., Koken, G. Y., & Mustafaoğlu, N. (2024) · FEBS Letters · doi:10.1002/1873-3468.15053 · Cited by 32
Engineering the Human Blood–Brain Barrier at the Capillary Scale using a Double‐Templating Technique
Zhao, N., Guo, Z., Kulkarni, S., Norman, D., Zhang, S., Chung, T. D., Nerenberg, R. F., Linville, R. M., & Searson, P. C. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202110289 · Cited by 31
Self-citationHosoya, M., & Czysz, K. (2016) · Cells · doi:10.3390/cells5040046 · Cited by 27
“Recent advances in the differentiation of human iPS cells into a variety of different cell types have enabled preparation of functional enterocyte-like cells [76], BBB endothelial cells [77,78] and renal tubules [79].”
BackgroundEndothelial Protrusions in Junctional Integrity and Barrier Function
Alves, N. G., Motawe, Z. Y., Yuan, S. Y., & Breslin, J. W. (2018) · Current topics in membranes · doi:10.1016/bs.ctm.2018.08.006 · Cited by 29
“Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions.”
BackgroundInfluentialLinville, R. M., Nerenberg, R. F., Grifno, G. N., Arevalo, D., Guo, Z., & Searson, P. C. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00347-7 · Cited by 28
“Differentiation was conducted by sequential treatment with mTeSR1 for 3 days, UM/F- for 6 days, and endothelial media (RA) for 2 days, as previously reported [15, 16] (Fig.”
BackgroundMethodInfluentialSelf-citationSalvador, E., Koeppl, T., Hörmann, J., Schönhärl, S., Bugaeva, P., Kessler, A. F., Burek, M., Ernestus, R., Löhr, M., & Hagemann, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010185 · Cited by 29
“stem cells (iPSCs)-derived human brain microvascular endothelial cells, one of which was reported to highly express the adherens and TJ-proteins VE-cadherin, ZO-1, occludin, and claudin-5 [17].”
BackgroundAn arduino-based sensor to measure transendothelial electrical resistance
Jones, C. G., & Chen, C. (2020) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2020.112216 · Cited by 27
Estimating Brain Permeability Using In Vitro Blood-Brain Barrier Models
Nozohouri, S., Noorani, B., Al-Ahmad, A. J., & Abbruscato, T. J. (2020) · Methods in molecular biology · doi:10.1007/7651_2020_311 · Cited by 27
Differential Effects of Retinoic Acid Concentrations in Regulating Blood–Brain Barrier Properties
Bonney, S. K., & Siegenthaler, J. A. (2017) · eNeuro · doi:10.1523/eneuro.0378-16.2017 · Cited by 25
“2013) and induced pluripotent stem cell (iPSC)-derived human brain ECs (Lippmann et al. 2014; Katt et al. 2016).”
BackgroundResultInfluentialLinville, R. M., DeStefano, J. G., Nerenberg, R. F., Grifno, G. N., Ye, R., Gallagher, E., & Searson, P. C. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00484 · Cited by 26
Self-citationOhtani-Kaneko, R., Sato, K., Tsutiya, A., Nakagawa, Y., 橋爪和俊, & Tazawa, H. (2017) · Biomedical Microdevices · doi:10.1007/s10544-017-0229-5 · Cited by 27
“However, all in vitro studies to date, with the exception of one that focused on the blood–brain barrier (Katt et al. 2016), have been carried out using stationary culture methods with standard culture flasks, wells, or transwell cell culture inserts.”
BackgroundModular tissue-in-a-CUBE platform to model blood-brain barrier (BBB) and brain interaction
Koh, I., & Hagiwara, M. (2024) · Communications Biology · doi:10.1038/s42003-024-05857-8 · Cited by 24
“These results are also much lower than the estimated 8000 Ω cm 2 reported in vivo 51 , and are also in contrast to other BBB models using iPSC-derived BMECwhereTEERvaluesover1000 Ω cm 2 aretypicallyreported,although these tend topeak at about day 1 or 2 before gradually decreasing 7,47,52 – 54 .”
Astrocytes and human artificial blood-brain barrier models
Zidarič, T., Gradišnik, L., & Velnar, T. (2022) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2021.6943 · Cited by 32
“For example, monolayers of iPSC-derived hBMECs TEER have values in the physiological range, especially when cultured with retinoic acid [79,80], indicating that astrocytes and pericytes are not per se essential for achieving physiological TEER values in in vitro models per se.”
BackgroundGallagher, E., Minn, I., Chambers, J. E., & Searson, P. C. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0035-0 · Cited by 22
“The reported efflux ratio for rhodamine in BC1-hBMEC cells is approximately 4 [19].”
BackgroundMethodInfluentialSelf-citationPage, S., Patel, R., Raut, S., & Al-Ahmad, A. J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.009 · Cited by 25
Song, L., Yan, Y., Marzano, M., & Li, Y. (2019) · Cells · doi:10.3390/cells8040299 · Cited by 22
“Based on the procedure developed by Lippmann t al for diff rentiating BMECs from hiPSCs [67], Katt et al reported a modified protocol and generated the brain endothelial cells with BBB phenotype [68,69].”
MethodDrug Delivery Systems and Strategies to Overcome the Barriers of Brain
Garg, Y., Kapoor, D. N., Sharma, A. K., & Bhatia, A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612828666211222163025 · Cited by 21
Nwokoye, P. N., & Abilez, O. J. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1336910 · Cited by 21
Hashimoto, Y., Michiba, K., Maeda, K., & Kusuhara, H. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.10.010 · Cited by 17
Galla, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.016 · Cited by 20
Girard, S. D., Julien‐Gau, I., Molino, Y., Combes, B. F., Greetham, L., Khrestchatisky, M., & Nivet, E. (2023) · The FASEB Journal · doi:10.1096/fj.202201422r · Cited by 18
“…2014, Wilson et al., 2015, Wilson et al., 2016, Hollmann et al., 2017, Qian et al., 2017, Neal et al., 2019) and adapted by many different groups (Katt et al., 2016, Mantle et al., 2016, Appelt-Menzel et al., 2017, Kokubu et al., 2017, Kurosawa et al., 2018, Ribecco-Lutkiewicz et al., 2018,…”
BackgroundA tissue-engineered model of the blood-tumor barrier during metastatic breast cancer
Linville, R. M., Maressa, J. C., Guo, Z., Chung, T. D., Farrell, A. M., Jha, R., & Searson, P. C. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00482-9 · Cited by 17
“Brain microvascular endothelial-like cells (iBMECs) were differentiated and then cryopreserved following published protocols [17–19].”
MethodSelf-citationOchocinska, M. J., Zloković, B. V., Searson, P. C., Crowder, A. T., Kraig, R. P., Ljubimova, J. Y., Mainprize, T. G., Banks, W. A., Warren, R. Q., Kindzelski, A., et al. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0061-6 · Cited by 16
“Similarly, brain microvascular endothelial cells resist elongation due to shear flow, which may be important in allowing the cells to wrap around and form tight junctions with themselves in brain capillaries [69, 70].”
Self-citationVignon, A., Salvador-Prince, L., Lehmann, S., Perrier, V., & Torrent, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168769 · Cited by 19
Neal, E. H., Katdare, K. A., Shi, Y., Marinelli, N. A., Hagerla, K. A., & Lippmann, E. S. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15532 · Cited by 16
Menéndez‐González, M., Tamba, B.-I., Leclere, M., Mabrouk, M., Schreiner, T. G., Ciobanu, R. C., & Tomás‐Zapico, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030768 · Cited by 16
“According to the classical paradigm, the primary role of the choroid plexus epithelial cells is the secretion of CSF into the brain ventricles; however, recent research acknowledges the protective role of the BCSFB for the cerebral parenchyma [5].”
BackgroundInfluentialReconstructing the Vascular Developmental Milieu In Vitro
Blatchley, M. R., & Gerecht, S. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.10.004 · Cited by 16
Self-citationCirculating MicroRNAs and Blood-Brain-Barrier Function in Breast Cancer Metastasis
Curtaz, C. J., Schmitt, C., Blecharz-Lang, K. G., Roewer, N., Wöckel, A., & Burek, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200316151720 · Cited by 16
Human iPSCs as Model Systems for BMP-Related Rare Diseases
Sánchez‐Duffhues, G., & Hiepen, C. (2023) · Cells · doi:10.3390/cells12172200 · Cited by 13
Stem cells and vascular dementia: from basic science to the clinic
Jiang, W., Gong, L., Liu, F., & Mu, J. (2020) · Cell and Tissue Banking · doi:10.1007/s10561-020-09829-0 · Cited by 12
Microtube-Embedded Microfluidic Devices for Potential Applications in Blood Brain Barrier Research
Sooriyaarachchi, D., Zhou, Y., Maharubin, S., & Tan, G. Z. (2020) · Procedia Manufacturing · doi:10.1016/j.promfg.2020.05.050 · Cited by 13
Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models
Bulboacă, A. E., Boarescu, P.-M., Melincovici, C. S., & Mihu, C. M. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.1.02 · Cited by 14
“Tight junctions can be evaluated by identification of several highly express adhesion proteins, such as VE-cadherin, ZO-1, occludin and claudin-5 [60].”
BackgroundOnyema, H. N., Berger, M., Musyanovych, A., Bantz, C., Maskos, M., & Freese, C. (2021) · Biointerphases · doi:10.1116/6.0000889 · Cited by 13
Xie, L., Wang, Y., & Chen, Z. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.02.011 · Cited by 10
Li, Y., Terstappen, G. C., & Zhang, W. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_363 · Cited by 12
Kriaučiūnaitė, K., Pociūtė, A., Kaušylė, A., Pajarskienė, J., Verkhratsky, A., & Pivoriūnas, A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30410 · Cited by 9
“Another investigation [30] used BCECs differentiated from human iPSCs according to the similar protocol as used by us.”
MethodDing, Y., Tamhankar, S., Du, F., Christopherson, T., Schlueter, N., Cohen, J. R., Shusta, E. V., & Palecek, S. P. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28979 · Cited by 11
“…2012). hPSC ‐ derived BBB models possess particular value as they offer robust platforms for studying BBB development (Dao et al. 2024; Gastfriend et al. 2021), disease modeling (Katt et al. 2016; Page et al. 2020; Sun et al. 2020), and drug screening (Li et al. 2019; Ohshima et al. 2019).”
Dai, Y., Zhao, F., Chen, Q., Zeng, B., Gu, W., Zhang, Y., Sun, F., Wang, X., Lin, X., Liu, N., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.08.035 · Cited by 21
“After cell seeding on 24-well Transwell inserts (3470, Corning), TEER was measured daily for one week, as previously described [94].”
Li, Y., Sun, Z., Zhu, H., Sun, Y., Shteyman, D. B., Markx, S., Leong, K. W., Xu, B., & Fu, B. M. (2023) · Cells · doi:10.3390/cells12030422 · Cited by 10
Vollmuth, N., Sin, J., & Kim, B. J. (2024) · mBio · doi:10.1128/mbio.02862-23 · Cited by 10
Thuringer, D., Solary, É., & Garrido, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00246 · Cited by 8
“These iPSC appeared also as a biological tools to screen neuropharmaceuticals (Lippmann et al., 2013, 2014a; Cecchelli et al., 2014; Minami et al., 2015; Katt et al., 2016; Appelt-Menzel et al., 2017; Yamamizu et al., 2017).”
BackgroundUsing miniature brain implants in rodents for novel drug discovery
Waldau, B. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1577816 · Cited by 8
Transcriptional Responses of In Vitro Blood–Brain Barrier Models to Shear Stress
Foreman, K. L., Gastfriend, B. D., Katt, M. E., Palecek, S. P., & Shusta, E. V. (2025) · Biomolecules · doi:10.3390/biom15020193 · Cited by 7
“Of particular interest to this study are induced pluripotent stem cell (iPSC)-derived BBB models, which can facilitate human disease modeling [26–28], as well as provide an isogenic source of other cell types of the NVU [29].”
Self-citationYan, L., Dwiggins, C. W., Gupta, U., & Stroka, K. M. (2023) · Bioengineering · doi:10.3390/bioengineering10091080 · Cited by 8
“We determined that the MATLAB “UNWRAP program” can be used to successfully reconstruct the 3D vessel and “unwrap” it into a 2D sheet [31].”
Metadata
- Authors
- Katt, M. E., Xu, Z. S., Gerecht, S., & Searson, P. C.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Searson, Peter C.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-04-12
- Volume
- 11
- Issue
- 4
- Pages
- e0152105
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4829259
- OpenAlex
- W2341259444
- Cited by
- 129
- References
- 48
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 12 · 2021: 16 · 2020: 18 · 2019: 20 · 2018: 11 · 2017: 12 · 2016: 5
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (R01CA170629)
- Defense Threat Reduction Agency (US) (HDTRA1-15-1-0046)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- human brain microvascular endothelial cells, blood-brain barrier, induced pluripotent stem cells, retinoic acid, tight junction proteins, VE-cadherin, claudin-5, transendothelial electrical resistance, efflux pumps, rhodamine 123 efflux, cell polarization, cell alignment, GFP-labeled cells
- MeSH terms
- Cadherin 5, Biological Transport, Blood-Brain Barrier, Brain, Capillaries, Cell Line, Humans, Phenotype, Antigens, CD, Cadherins, Up-Regulation, Tight Junctions, Rhodamine 123, Endothelial Cells, Induced Pluripotent Stem Cells, Claudin-5, Occludin, Zonula Occludens-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.